<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7122247\results\search\drugs\results.xml">
  <result pre="(Turk 2006), as well as the neprilysin (enkephalinase) inhibitor prodrugs" exact="sacubitril" post="(Howell and Cameron 2016) and racecadotril (acetorphan) target Zn2+-dependent"/>
  <result pre="and racecadotril (acetorphan) target Zn2+-dependent metalloproteases. The ACE blockers and" exact="sacubitril" post="are suitable for long-term usage as antihypertensive drugs, whereas"/>
  <result pre="synthetic inhibitors of the trypsin-like serine proteases (TLSP) thrombin (argatroban," exact="dabigatran" post="etexilate, bivalirudin) and factor Xa (rivaroxaban, apixaban, edoxaban, betrixaban)"/>
  <result pre="to an enhanced insulin secretion (Scheen 2015). The proteasome inhibitors" exact="bortezomib" post="(Adams 2004) and carfilzomib (Kortuem and Stewart 2013) are"/>
  <result pre="secretion (Scheen 2015). The proteasome inhibitors bortezomib (Adams 2004) and" exact="carfilzomib" post="(Kortuem and Stewart 2013) are used in patients with"/>
  <result pre="approved drugs targeting threonine proteases. Meanwhile, two additional proteasome inhibitors," exact="ixazomib" post="and oprozomib, obtained orphan drug status (Manasanch and Orlowski"/>
  <result pre="antiviral strategy was supported by studies with the broad-spectrum inhibitor" exact="aprotinin" post="(1) in mice (Ovcharenko and Zhirnov 1994; Zhirnov et"/>
  <result pre="trypsin is shown in Fig. 11.1. Fig. 11.1 Structure of" exact="aprotinin" post="(1) in complex with trypsin (PDB, 3FP6). Trypsin is"/>
  <result pre="(PDB, 3FP6). Trypsin is shown with its surface in beige," exact="aprotinin" post="as cartoon in green. Only the aprotinin residues in"/>
  <result pre="surface in beige, aprotinin as cartoon in green. Only the" exact="aprotinin" post="residues in direct contact to the trypsin surface (Pro13-Cys-Lys-Ala-Arg17"/>
  <result pre="after reexposure (Levy and Adkinson 2008). However, the application of" exact="aprotinin" post="against influenza in form of an aerosol at significantly"/>
  <result pre="minimize side effects (Zhirnov et al. 2011). In addition, an" exact="aprotinin" post="variant with stronger kallikrein and similar plasmin inhibition has"/>
  <result pre="the secretory pathway. Despite this limitation, an aerosol formulation of" exact="aprotinin" post="has been developed and approved in Russia for the"/>
  <result pre="et al. 2010, 2013). This suggests that small amounts of" exact="aprotinin" post="can reach intracellular targets and achieve an antiviral efficacy"/>
  <result pre="used for the development of the orally available thrombin inhibitor" exact="ximelagatran" post="(Gustafsson et al. 2004). The conversion of the P1-amidine"/>
  <result pre="due to the discovery of more suited non-covalent inhibitors, like" exact="melagatran" post="containing the 4-Amba residue. The arginal derivative 14 acylated"/>
  <result pre="1999) (WX-UK1, Fig. 11.9) in combination with the 5-fluorouracil prodrug" exact="capecitabine" post="reached clinical development for tumor therapy (Setyono-Han et al."/>
  <result pre="et al. 2013), respectively. Surprisingly, also the mucolytic cough suppressant" exact="bromhexine" post="30 was described as TMPRSS2 inhibitor (IC50 = 0.75"/>
  <result pre="plasmin. Further modification of the P3 position by tert-leucine or" exact="penicillamine" post="provided inhibitors with enhanced potencies (Becker et al. 2011;"/>
  <result pre="Podsiadlo et al. 2004; Sielaff et al. 2011b) Furthermore, furin-inhibiting" exact="dicoumarol" post="derivatives could be identified by HTS. Some of these"/>
  <result pre="Sci20119915010.1016/B978-0-12-385504-6.00001-421238933 ApelerHPetersJSchröderWSchneiderKHLemmGHinzVRossouwGJDembowskyKExpression, purification, biochemical and pharmacological characterization of a recombinant" exact="aprotinin" post="variantArzneimittelforschung20045448349715460216 AscenziPBocediABolognesiMSpallarossaAColettaMDe CristofaroRMenegattiEThe bovine basic pancreatic trypsin inhibitor (Kunitz"/>
  <result pre="protease inhibitorsJ Enzyme Inhib Med Chem20132846847810.3109/14756366.2011.65146622380780 FergussonDAHebertPCMazerCDFremesSMacAdamsCMurkinJMTeohKDukePCArellanoRBlajchmanMAet al.A comparison of" exact="aprotinin" post="and lysine analogues in high-risk cardiac surgeryN Engl J"/>
  <result pre="its receptor CD26Nature201350022723110.1038/nature1232823831647 LuYHardesKDahmsSOBöttcher-FriebertshäuserESteinmetzerTThanMEKlenkHDGartenWPeptidomimetic furin inhibitor MI-701 in combination with" exact="oseltamivir" post="and ribavirin efficiently blocks propagation of highly pathogenic avian"/>
  <result pre="CD26Nature201350022723110.1038/nature1232823831647 LuYHardesKDahmsSOBöttcher-FriebertshäuserESteinmetzerTThanMEKlenkHDGartenWPeptidomimetic furin inhibitor MI-701 in combination with oseltamivir and" exact="ribavirin" post="efficiently blocks propagation of highly pathogenic avian influenza viruses"/>
  <result pre="of highly pathogenic avian influenza viruses and delays high level" exact="oseltamivir" post="resistance in MDCK cellsAntiviral Res20151208910010.1016/j.antiviral.2015.05.00626022200 LucasJMHeinleinCKimTHernandezSAMalikMSTrueLDMorrisseyCCoreyEMontgomeryBMostaghelEet al.The androgen-regulated protease"/>
  <result pre="and reduction of primary tumour growth by the small synthetic" exact="urokinase" post="inhibitor WX-UK1Thromb Haemost20059377978615841327 ShiratoKazuyaKanouKazuhikoKawaseMiyukiMatsuyamaShutokuClinical Isolates of Human Coronavirus 229E"/>
  <result pre="Med Chem1997403091309910.1021/jm960668h9301673 StürzebecherJViewegHSteinmetzerTSchweinitzAStubbsMTRenatusMWikströmP3-Amidinophenylalanine-based inhibitors of urokinaseBioorg Med Chem Lett199993147315210.1016/S0960-894X(99)00541-710560742 StürzebecherJSchweinitzASchmalixWAWikströmPSynthetic" exact="urokinase" post="inhibitors as potential anti-invasive drugsIDrugs2001467768316001312 SwedbergJEHarrisJMPlasmin substrate binding site"/>
  <result pre="complex with Sunflower trypsin inhibitor-1BMC Struct Biol2011113010.1186/1472-6807-11-3021693064 ZeslawskaESchweinitzAKarcherASondermannPSperlSStürzebecherJJacobUCrystals of the" exact="urokinase" post="type plasminogen activator variant beta(c)-uPAin complex with small molecule"/>
 </snippets>
</snippetsTree>
